377391009: Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral tablet (clinical drug)

SNOMED CT Concept\Pharmaceutical / biologic product (product)\Medicinal product (product)\...

\Medicinal product categorized by disposition (product)\Product containing histamine receptor antagonist (product)\Ethanolamine derivative histamine receptor antagonist product\Product containing phenyltoloxamine (medicinal product)\Product containing paracetamol and phenyltoloxamine (medicinal product)\...

\Product containing paracetamol and phenyltoloxamine in oral dose form (medicinal product form)\Paracetamol- and phenyltoloxamine- and salicylamide-containing product in oral dose form\Product containing only paracetamol and phenyltoloxamine and salicylamide in oral dose form (medicinal product form)\Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet

\Product containing paracetamol and phenyltoloxamine and salicylamide (medicinal product)\Paracetamol and phenyltoloxamine and salicylamide only product\Product containing only paracetamol and phenyltoloxamine and salicylamide in oral dose form (medicinal product form)\Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet
\Product containing paracetamol and phenyltoloxamine and salicylamide (medicinal product)\Paracetamol- and phenyltoloxamine- and salicylamide-containing product in oral dose form\Product containing only paracetamol and phenyltoloxamine and salicylamide in oral dose form (medicinal product form)\Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet

\Medicinal product categorized by structure\Product containing organic acid and/or organic acid derivative (product)\Carboxylic acid and/or carboxylic acid derivative-containing product\Product containing salicylate (product)\Product containing salicylamide (medicinal product)\Product containing paracetamol and salicylamide (medicinal product)\Paracetamol- and salicylamide-containing product in oral dose form\Paracetamol- and phenyltoloxamine- and salicylamide-containing product in oral dose form\Product containing only paracetamol and phenyltoloxamine and salicylamide in oral dose form (medicinal product form)\Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet
\Medicinal product categorized by structure\Product containing organic acid and/or organic acid derivative (product)\Carboxylic acid and/or carboxylic acid derivative-containing product\Product containing salicylate (product)\Product containing salicylamide (medicinal product)\Product containing paracetamol and salicylamide (medicinal product)\Product containing paracetamol and phenyltoloxamine and salicylamide (medicinal product)\Paracetamol and phenyltoloxamine and salicylamide only product\Product containing only paracetamol and phenyltoloxamine and salicylamide in oral dose form (medicinal product form)\Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet
\Medicinal product categorized by structure\Product containing organic acid and/or organic acid derivative (product)\Carboxylic acid and/or carboxylic acid derivative-containing product\Product containing salicylate (product)\Product containing salicylamide (medicinal product)\Product containing paracetamol and salicylamide (medicinal product)\Product containing paracetamol and phenyltoloxamine and salicylamide (medicinal product)\Paracetamol- and phenyltoloxamine- and salicylamide-containing product in oral dose form\Product containing only paracetamol and phenyltoloxamine and salicylamide in oral dose form (medicinal product form)\Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet
\Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing ethanolamine and/or ethanolamine derivative (product)\Ethanolamine derivative histamine receptor antagonist product\Product containing phenyltoloxamine (medicinal product)\Product containing paracetamol and phenyltoloxamine (medicinal product)\Product containing paracetamol and phenyltoloxamine in oral dose form (medicinal product form)\Paracetamol- and phenyltoloxamine- and salicylamide-containing product in oral dose form\Product containing only paracetamol and phenyltoloxamine and salicylamide in oral dose form (medicinal product form)\Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet
\Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing ethanolamine and/or ethanolamine derivative (product)\Ethanolamine derivative histamine receptor antagonist product\Product containing phenyltoloxamine (medicinal product)\Product containing paracetamol and phenyltoloxamine (medicinal product)\Product containing paracetamol and phenyltoloxamine and salicylamide (medicinal product)\Paracetamol and phenyltoloxamine and salicylamide only product\Product containing only paracetamol and phenyltoloxamine and salicylamide in oral dose form (medicinal product form)\Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet
\Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing ethanolamine and/or ethanolamine derivative (product)\Ethanolamine derivative histamine receptor antagonist product\Product containing phenyltoloxamine (medicinal product)\Product containing paracetamol and phenyltoloxamine (medicinal product)\Product containing paracetamol and phenyltoloxamine and salicylamide (medicinal product)\Paracetamol- and phenyltoloxamine- and salicylamide-containing product in oral dose form\Product containing only paracetamol and phenyltoloxamine and salicylamide in oral dose form (medicinal product form)\Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet
\Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing paracetamol (medicinal product)\Product containing paracetamol and phenyltoloxamine (medicinal product)\Product containing paracetamol and phenyltoloxamine in oral dose form (medicinal product form)\Paracetamol- and phenyltoloxamine- and salicylamide-containing product in oral dose form\Product containing only paracetamol and phenyltoloxamine and salicylamide in oral dose form (medicinal product form)\Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet
\Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing paracetamol (medicinal product)\Product containing paracetamol and phenyltoloxamine (medicinal product)\Product containing paracetamol and phenyltoloxamine and salicylamide (medicinal product)\Paracetamol and phenyltoloxamine and salicylamide only product\Product containing only paracetamol and phenyltoloxamine and salicylamide in oral dose form (medicinal product form)\Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet
\Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing paracetamol (medicinal product)\Product containing paracetamol and phenyltoloxamine (medicinal product)\Product containing paracetamol and phenyltoloxamine and salicylamide (medicinal product)\Paracetamol- and phenyltoloxamine- and salicylamide-containing product in oral dose form\Product containing only paracetamol and phenyltoloxamine and salicylamide in oral dose form (medicinal product form)\Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet
\Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing paracetamol (medicinal product)\Product containing paracetamol in oral dose form (medicinal product form)\Paracetamol- and salicylamide-containing product in oral dose form\Paracetamol- and phenyltoloxamine- and salicylamide-containing product in oral dose form\Product containing only paracetamol and phenyltoloxamine and salicylamide in oral dose form (medicinal product form)\Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet
\Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing paracetamol (medicinal product)\Product containing paracetamol in oral dose form (medicinal product form)\Product containing paracetamol and phenyltoloxamine in oral dose form (medicinal product form)\Paracetamol- and phenyltoloxamine- and salicylamide-containing product in oral dose form\Product containing only paracetamol and phenyltoloxamine and salicylamide in oral dose form (medicinal product form)\Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet
\Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing paracetamol (medicinal product)\Product containing paracetamol and salicylamide (medicinal product)\Paracetamol- and salicylamide-containing product in oral dose form\Paracetamol- and phenyltoloxamine- and salicylamide-containing product in oral dose form\Product containing only paracetamol and phenyltoloxamine and salicylamide in oral dose form (medicinal product form)\Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet
\Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing paracetamol (medicinal product)\Product containing paracetamol and salicylamide (medicinal product)\Product containing paracetamol and phenyltoloxamine and salicylamide (medicinal product)\Paracetamol and phenyltoloxamine and salicylamide only product\Product containing only paracetamol and phenyltoloxamine and salicylamide in oral dose form (medicinal product form)\Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet
\Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing paracetamol (medicinal product)\Product containing paracetamol and salicylamide (medicinal product)\Product containing paracetamol and phenyltoloxamine and salicylamide (medicinal product)\Paracetamol- and phenyltoloxamine- and salicylamide-containing product in oral dose form\Product containing only paracetamol and phenyltoloxamine and salicylamide in oral dose form (medicinal product form)\Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet
\Medicinal product categorized by structure\Phenol structure-containing product\Product containing paracetamol (medicinal product)\Product containing paracetamol and phenyltoloxamine (medicinal product)\Product containing paracetamol and phenyltoloxamine in oral dose form (medicinal product form)\Paracetamol- and phenyltoloxamine- and salicylamide-containing product in oral dose form\Product containing only paracetamol and phenyltoloxamine and salicylamide in oral dose form (medicinal product form)\Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet
\Medicinal product categorized by structure\Phenol structure-containing product\Product containing paracetamol (medicinal product)\Product containing paracetamol and phenyltoloxamine (medicinal product)\Product containing paracetamol and phenyltoloxamine and salicylamide (medicinal product)\Paracetamol and phenyltoloxamine and salicylamide only product\Product containing only paracetamol and phenyltoloxamine and salicylamide in oral dose form (medicinal product form)\Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet
\Medicinal product categorized by structure\Phenol structure-containing product\Product containing paracetamol (medicinal product)\Product containing paracetamol and phenyltoloxamine (medicinal product)\Product containing paracetamol and phenyltoloxamine and salicylamide (medicinal product)\Paracetamol- and phenyltoloxamine- and salicylamide-containing product in oral dose form\Product containing only paracetamol and phenyltoloxamine and salicylamide in oral dose form (medicinal product form)\Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet
\Medicinal product categorized by structure\Phenol structure-containing product\Product containing paracetamol (medicinal product)\Product containing paracetamol in oral dose form (medicinal product form)\Paracetamol- and salicylamide-containing product in oral dose form\Paracetamol- and phenyltoloxamine- and salicylamide-containing product in oral dose form\Product containing only paracetamol and phenyltoloxamine and salicylamide in oral dose form (medicinal product form)\Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet
\Medicinal product categorized by structure\Phenol structure-containing product\Product containing paracetamol (medicinal product)\Product containing paracetamol in oral dose form (medicinal product form)\Product containing paracetamol and phenyltoloxamine in oral dose form (medicinal product form)\Paracetamol- and phenyltoloxamine- and salicylamide-containing product in oral dose form\Product containing only paracetamol and phenyltoloxamine and salicylamide in oral dose form (medicinal product form)\Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet
\Medicinal product categorized by structure\Phenol structure-containing product\Product containing paracetamol (medicinal product)\Product containing paracetamol and salicylamide (medicinal product)\Paracetamol- and salicylamide-containing product in oral dose form\Paracetamol- and phenyltoloxamine- and salicylamide-containing product in oral dose form\Product containing only paracetamol and phenyltoloxamine and salicylamide in oral dose form (medicinal product form)\Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet
\Medicinal product categorized by structure\Phenol structure-containing product\Product containing paracetamol (medicinal product)\Product containing paracetamol and salicylamide (medicinal product)\Product containing paracetamol and phenyltoloxamine and salicylamide (medicinal product)\Paracetamol and phenyltoloxamine and salicylamide only product\Product containing only paracetamol and phenyltoloxamine and salicylamide in oral dose form (medicinal product form)\Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet
\Medicinal product categorized by structure\Phenol structure-containing product\Product containing paracetamol (medicinal product)\Product containing paracetamol and salicylamide (medicinal product)\Product containing paracetamol and phenyltoloxamine and salicylamide (medicinal product)\Paracetamol- and phenyltoloxamine- and salicylamide-containing product in oral dose form\Product containing only paracetamol and phenyltoloxamine and salicylamide in oral dose form (medicinal product form)\Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet

\Product manufactured as oral dose form (product)\Product containing paracetamol in oral dose form (medicinal product form)\...

\Paracetamol- and salicylamide-containing product in oral dose form\Paracetamol- and phenyltoloxamine- and salicylamide-containing product in oral dose form\Product containing only paracetamol and phenyltoloxamine and salicylamide in oral dose form (medicinal product form)\Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet

\Product containing paracetamol and phenyltoloxamine in oral dose form (medicinal product form)\Paracetamol- and phenyltoloxamine- and salicylamide-containing product in oral dose form\Product containing only paracetamol and phenyltoloxamine and salicylamide in oral dose form (medicinal product form)\Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3501675015 Acetaminophen 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3501676019 Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3681523016 Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet	Is a	Acetaminophen compound preparation	false	Inferred relationship	Some
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet	Is a	Product containing phenyltoloxamine (medicinal product)	false	Inferred relationship	Some
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Ethanolamine	false	Inferred relationship	Some
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Sedating antihistamine	false	Inferred relationship	Some
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Non-opioid analgesic (substance)	false	Inferred relationship	Some
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Phenyltoloxamine (substance)	false	Inferred relationship	Some
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet	Is a	Product containing paracetamol and phenyltoloxamine citrate and salicylamide	false	Inferred relationship	Some
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Paracetamol	false	Inferred relationship	Some
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Salicylamide	false	Inferred relationship	Some
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Phenyltoloxamine citrate	false	Inferred relationship	Some
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet	Has manufactured dose form	A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition.	false	Inferred relationship	Some
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Cardiovascular agent (substance)	false	Inferred relationship	Some
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet	Has manufactured dose form	Oral tablet	true	Inferred relationship	Some
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet	Is a	Product containing paracetamol in oral dose form (medicinal product form)	false	Inferred relationship	Some
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet	This attribute specifies the numerator unit for the presentation strength of a product.	mg	true	Inferred relationship	Some	1
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet	Has presentation strength denominator value	un	false	Inferred relationship	Some	1
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet	This attribute specifies the denominator unit for the presentation strength of a product.	Tablet (unit of presentation)	true	Inferred relationship	Some	1
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet	This attribute specifies the numerator unit for the presentation strength of a product.	mg	true	Inferred relationship	Some	2
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet	Has presentation strength denominator value	un	false	Inferred relationship	Some	2
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet	This attribute specifies the denominator unit for the presentation strength of a product.	Tablet (unit of presentation)	true	Inferred relationship	Some	2
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet	This attribute specifies the numerator unit for the presentation strength of a product.	mg	true	Inferred relationship	Some	3
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet	Has presentation strength denominator value	un	false	Inferred relationship	Some	3
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet	This attribute specifies the denominator unit for the presentation strength of a product.	Tablet (unit of presentation)	true	Inferred relationship	Some	3
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	Paracetamol	false	Inferred relationship	Some	1
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet	Has presentation strength numerator value	300	false	Inferred relationship	Some	1
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Phenyltoloxamine citrate	false	Inferred relationship	Some	3
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	Phenyltoloxamine citrate	false	Inferred relationship	Some	3
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet	Has presentation strength numerator value	20	false	Inferred relationship	Some	3
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Salicylamide	false	Inferred relationship	Some	1
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	Salicylamide	false	Inferred relationship	Some	1
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet	Has presentation strength numerator value	200	false	Inferred relationship	Some	1
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	Phenyltoloxamine citrate	false	Inferred relationship	Some	2
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet	Has presentation strength numerator value	20	false	Inferred relationship	Some	2
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	Salicylamide	false	Inferred relationship	Some	3
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet	Has presentation strength numerator value	200	false	Inferred relationship	Some	3
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Paracetamol	false	Inferred relationship	Some	2
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	Paracetamol	false	Inferred relationship	Some	2
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet	Has presentation strength numerator value	300	false	Inferred relationship	Some	2
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	Salicylamide	false	Inferred relationship	Some	3
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet	Has unit of presentation	Tablet (unit of presentation)	true	Inferred relationship	Some
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	Phenyltoloxamine citrate	false	Inferred relationship	Some	2
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	Paracetamol	false	Inferred relationship	Some	1
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet	Is a	Paracetamol- and phenyltoloxamine- and salicylamide-containing product in oral dose form	false	Inferred relationship	Some
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet	Count of base of active ingredient	trois	false	Inferred relationship	Some
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet	Is a	Product containing only paracetamol and phenyltoloxamine and salicylamide in oral dose form (medicinal product form)	true	Inferred relationship	Some
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	Salicylamide	true	Inferred relationship	Some	2
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	Phenyltoloxamine citrate	true	Inferred relationship	Some	1
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	Paracetamol	true	Inferred relationship	Some	3
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	Salicylamide	true	Inferred relationship	Some	2
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	Paracetamol	true	Inferred relationship	Some	3
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	Phenyltoloxamine citrate	true	Inferred relationship	Some	1

Inbound Relationships

Type

Active

Source

Characteristic

Refinability

Group

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3501675015	Acetaminophen 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3501676019	Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3681523016	Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral tablet (clinical drug)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core